Novartis/Ophthotech eye combo fails in phase 3Lucentis and pegpleranib combination misses goal in wet AMD. Share XNovartis/Ophthotech eye combo fails in phase 3https://pharmaphorum.com/news/novartisophthotech-eye-combo-fails-phase-3/